Profit with us in the 2009 bear market
   

Recent Material Events - Geopharma (GORX)

Filing Date Description
2009-11-17 If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate) ...
2009-10-21 3 Certificate of Designation Creating Series C Convertible Preferred Stock 10.1 Second Restated Whitebox Agreement 10.2 $10,000,000 Second Restated Note 10.3 $5,000,000 Second Restated Note 10.4 ...
2009-08-17 On August 17, 2009, GeoPharma, Inc. issued a press release announcing its results of operations as of and for the three months ended June 30, 2009, a copy of which is attached as Exhibit 99.1 hereto. ...
2009-07-15 On July 10, 2009, the Company completed the sale of a substantial portion of the inventory, accounts receivable and other assets (the “Assets”) of the BOSS division of its subsidiary, Dynamic Health Products, Inc. (“BOSS”), to USA ...
2009-07-02 In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amen ...
2009-06-30 GEOPHARMA, INC. Full Name of Registrant Former Name if Applicable 6950 Bryan Dairy Road Address of Principal Executive Office (Street and Number) Largo, FL 33777 City, State and Zip Code ...
2009-06-30 In regards to the table below, note that the results of operations of our PBM segment, whose operations were discontinued effective May 15, 2007, are included in the selected quarterly data below. In addition, the results of operations of BOSS are al ...
2009-01-27 On January 26, 2009, GeoPharma, Inc. (the "Company") entered into an agreement with Trident Biotech, Inc. ("Trident"). Under the terms of the agreement, Trident will purchase a majority stake in the Company's Ovarian Cancer business for a total of $2 ...
2008-12-11 As previously reported, on April 24, 2008, the Company and Whitebox entered into an Amended and Restated Note Purchase Agreement (the "Restated Note Purchase Agreement") and certain other transaction documents described in the Restated Note Purchase ...
2008-12-10 On December 8, 2008, a holder of 1,025 shares of GeoPharma, Inc. ("Company") 6% convertible preferred stock, Series B, $.01 par value, converted such shares into 235,092 shares of Company common stock, at a set conversion price of $4.36 per common sh ...
   
 
Home > Companies > Geopharma > Recent Material Events
Home | Message boards | Newsletters | Latest Comments | AIM London Stock Exchange | Canadian stocks | Chinese stocks
About us | Privacy Policy | Disclaimer | Compensation Disclosure | Contributors | Contact form
© 2007 - 2009 hotstocked.com - All rights reserved.